Sana Biotechnology, Inc.
SANA- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001770121
No open-market purchases or sales by Sana Biotechnology, Inc. insiders were filed in the last 90 days; 211 institutions reported holding it in 13F filings for Q2 2026, worth $644.7M in total; no superinvestor holds it.
13F holders, Q4 2021
Institutional positions in Sana Biotechnology, Inc. as of Dec 31, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 105
- +19 vs. Q3 2021
- Shares held
- 111.6M
- +1.88M (+1.7%) vs. Q3 2021
- Total value
- $1.73B
- −$744.0M (−30.1%) vs. Q3 2021
- New holders
- 30
- 41 more added
- Sold out
- 11
- 13 more reduced
2 institutions that held it in Q3 2021 haven't filed for Q4 2021 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q3 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting SANA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 211 | $644.7M |
| Q1 2026 | 203 | $473.1M |
| Q4 2025 | 203 | $648.8M |
| Q3 2025 | 178 | $581.8M |
| Q2 2025 | 155 | $396.9M |
| Q1 2025 | 161 | $250.6M |
| Q4 2024 | 164 | $257.4M |
| Q3 2024 | 155 | $638.8M |
| Q2 2024 | 148 | $810.3M |
| Q1 2024 | 154 | $1.46B |
| Q4 2023 | 132 | $508.1M |
| Q3 2023 | 136 | $493.5M |
| Q2 2023 | 123 | $804.1M |
| Q1 2023 | 120 | $427.4M |
| Q4 2022 | 120 | $507.0M |
| Q3 2022 | 125 | $769.7M |
| Q2 2022 | 116 | $807.5M |
| Q1 2022 | 117 | $985.8M |
| Q4 2021 | 105 | $1.73B |
| Q3 2021 | 88 | $2.48B |
| Q2 2021 | 80 | $1.93B |
| Q1 2021 | 78 | $3.10B |
Institutions, Q4 2021
Shares, value and share of portfolio for each institution holding Sana Biotechnology, Inc.; share changes are against Q3 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Vanguard Group Inc | 7,708,151 | $119.3M | 0.00% | +119,607+1.6% | Added |
| FMR LLC | 8,627,851 | $133.6M | 0.01% | +175,107+2.1% | Added |
| Canada Pension Plan Investment Board | 10,175,000 | $157.5M | 0.17% | 00.0% | Unchanged |
| Baillie Gifford & Co | 11,262,030 | $174.3M | 0.10% | +72,198+0.6% | Added |
| Flagship Pioneering Inc. | 34,239,018 | $530.0M | 8.19% | 00.0% | Unchanged |
| Avidity Partners Management LP | 0 | $0 | 0.00% | −774,644−100.0% | Sold out |
| Gilder Gagnon Howe & Co LLC | 0 | $0 | 0.00% | −402,961−100.0% | Sold out |
| Alyeska Investment Group, L.P. | 0 | $0 | 0.00% | −40,000−100.0% | Sold out |
| Franklin Resources Inc | 0 | $0 | 0.00% | −14,032−100.0% | Sold out |
| Tarbox Family Office, Inc. | 0 | $0 | 0.00% | −2,000−100.0% | Sold out |
| Loomis Sayles & Co L P | 0 | $0 | 0.00% | −502−100.0% | Sold out |
| Manchester Capital Management LLC | 0 | $0 | 0.00% | −300−100.0% | Sold out |
| Jacobi Capital Management LLC | 0 | $0 | 0.00% | −100−100.0% | Sold out |
| TFC Financial Management | 0 | $0 | 0.00% | −88−100.0% | Sold out |
| Massmutual Trust Co FSB | 0 | $0 | 0.00% | −26−100.0% | Sold out |
| Advisor Group Holdings, Inc. | 0 | $0 | 0.00% | −22−100.0% | Sold out |
| Trustees of Columbia University in the City of New York | – | – | – | – | Not filed |
| Berman Capital Advisors, LLC | – | – | – | – | Not filed |